Evidence map›Paper›PMID 26833329›Full record

ArticleAmerican journal of human genetics2016

Small 6q16.1 Deletions Encompassing POU3F2 Cause Susceptibility to Obesity and Variable Developmental Delay with Intellectual Disability.

Paul R Kasher, Katherine E Schertz, Megan Thomas, Adam Jackson, Silvia Annunziata, María J Ballesta-Martinez, Philippe M Campeau, Peter E Clayton, Jennifer L Eaton, Tiziana Granata and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Network Structure Analysis Identifying Key Genes of Autism and Its Mechanism.Computational and mathematical methods in medicine · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 14 institutions in 7 countries.

Paul R KasherManchester Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester M13 9WL, UK.
Katherine E SchertzDepartment of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.
Megan ThomasChild Health Directorate, Blackpool Teaching Hospitals, Blackpool FY3 8NR, UK; Faculty of Health and Medicine, University of Lancaster, Lancaster LA1 4YW, UK.
Adam JacksonChild Health Directorate, Blackpool Teaching Hospitals, Blackpool FY3 8NR, UK.
Silvia AnnunziataFondazione I.R.C.C.S. Istituto Neurologico "C. Besta," Milan 20133, Italy.
María J Ballesta-MartinezSección de Genética Médica, Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, Cátedra de Genética, UCAM, 30120 Murcia, Spain.
Philippe M CampeauDepartment of Paediatrics, University of Montreal, Montréal, QC H3T 1J4, Canada.
Peter E ClaytonCentre for Paediatrics & Child Health, Institute of Human Development, University of Manchester, Manchester M13 9WL, UK.
Jennifer L EatonSumma Health System, Akron, OH 44304, USA.
Tiziana GranataFondazione I.R.C.C.S. Istituto Neurologico "C. Besta," Milan 20133, Italy.
Encarna Guillén-NavarroSección de Genética Médica, Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, Cátedra de Genética, UCAM, 30120 Murcia, Spain.
Cristina HernandoQuantitative Genomic Medicine Laboratories (qGenomics), 08950 Barcelona, Spain.
Caroline E LaverriereDepartment of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.
Agne LiedénMedical Genetics, St George's University Hospitals NHS Foundation Trust, London SW17 0QT, UK.
Olaya Villa-MarcosQuantitative Genomic Medicine Laboratories (qGenomics), 08950 Barcelona, Spain.
Meriel McEntagartMedical Genetics, St George's University Hospitals NHS Foundation Trust, London SW17 0QT, UK.
Ann NordgrenDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm 171 76, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm 171 76, Sweden.
Chiara PantaleoniFondazione I.R.C.C.S. Istituto Neurologico "C. Besta," Milan 20133, Italy.
Céline Pebrel-RichardCytogénétique Médicale, CHU-Estaing, 63003 Clermont-Ferrand, France.
Catherine SarretGénétique Médicale, Hôpital Estaing, CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France.
Francesca L SciaccaFondazione I.R.C.C.S. Istituto Neurologico "C. Besta," Milan 20133, Italy.
Ronnie WrightManchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre (MAHSC), Manchester M13 9WL, UK.
Bronwyn KerrManchester Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester M13 9WL, UK; Manchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre (MAHSC), Manchester M13 9WL, UK.
Eric GlasgowDepartment of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.
Siddharth BankaManchester Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester M13 9WL, UK; Manchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre (MAHSC), Manchester M13 9WL, UK. Electronic address: siddharth.banka@manchester.ac.uk.
Fondazione IRCCS Istituto Neurologico Carlo Besta · ITUniversity of Manchester · GBGeorgetown University · USHospital Universitario Virgen de la Arrixaca · ESQuantitative Genomics Medicine Laboratories (qGenomics)St George’s University Hospitals NHS Foundation Trust · GBBlackpool Teaching Hospitals NHS Foundation Trust · GBCentre Hospitalier Universitaire de Clermont-Ferrand · FRGénétique Médicale & Génomique Fonctionelle · FRKarolinska Institutet · SELancaster University · GBSt Mary's Hospital · GBSumma Health System · USUniversité de Montréal · CA

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI Louis M Weiner · 1990 to 2026
$71.5M
NCI NIH HHS CA51008NCI NIH HHS P30 CA051008PHS HHS RN315908PHS HHS RN324373
6 · The paper itself

Abstract

Genetic studies of intellectual disability and identification of monogenic causes of obesity in humans have made immense contribution toward the understanding of the brain and control of body mass. The leptin > melanocortin > SIM1 pathway is dysregulated in multiple monogenic human obesity syndromes but its downstream targets are still unknown. In ten individuals from six families, with overlapping 6q16.1 deletions, we describe a disorder of variable developmental delay, intellectual disability, and susceptibility to obesity and hyperphagia. The 6q16.1 deletions segregated with the phenotype in multiplex families and were shown to be de novo in four families, and there was dramatic phenotypic overlap among affected individuals who were independently ascertained without bias from clinical features. Analysis of the deletions revealed a ∼350 kb critical region on chromosome 6q16.1 that encompasses a gene for proneuronal transcription factor POU3F2, which is important for hypothalamic development and function. Using morpholino and mutant zebrafish models, we show that POU3F2 lies downstream of SIM1 and controls oxytocin expression in the hypothalamic neuroendocrine preoptic area. We show that this finding is consistent with the expression patterns of POU3F2 and related genes in the human brain. Our work helps to further delineate the neuro-endocrine control of energy balance/body mass and demonstrates that this molecular pathway is conserved across multiple species.

Indexed as

Sequence DeletionAdolescentAdultAnimalsBasic Helix-Loop-Helix ProteinsBody Mass IndexCell LineChildChild, PreschoolChromosomes, Human, Pair 6Disease Models, AnimalEnergy MetabolismFemaleHomeodomain ProteinsHumansHypothalamusBasic Helix-Loop-Helix ProteinsHomeodomain ProteinsOxytocinPOU Domain FactorsRepressor ProteinsSIM1 protein, humantranscription factor Brn-26q16intellectual disabilityobesityoxytocinPOU3F2 (also called BRN2 or N-OCT3 or OCT7)SIM1

Identifiers

PMID26833329
PMCPMC4746363
OpenAlexW2266644715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.